Literature DB >> 564552

Compulsive, abnormal walking caused by anticholinergics in akinetic, 6-hydroxydopamine-treated rats.

T Schallert, I Q Whishaw, V D Ramirez, P Teitelbaum.   

Abstract

In otherwise profoundly akinetic rats that had been severely depleted of brain catecholamines, anticholinergic drugs caused excessive walking. The effect did not appear until 10 days after surgery and then increased with time, suggesting that a phenomenon analogous to denervation supersensitivity may be involved. If the animals walked into corners, they were unable to turn around or back out. Their gait (extremely short steps) was reminiscent of that of patients with Parkinson's disease. The results are consistent with a mutually antagonistic interaction between cholinergic and dopaminergic brain systems and emphasize certain complexities in this interaction.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 564552     DOI: 10.1126/science.564552

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  17 in total

1.  Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein.

Authors:  S M Fleming; J Salcedo; C B Hutson; E Rockenstein; E Masliah; M S Levine; M-F Chesselet
Journal:  Neuroscience       Date:  2006-08-23       Impact factor: 3.590

2.  Quantitative Analysis of Catecholamines in the Pink1 -/- Rat Model of Early-onset Parkinson's Disease.

Authors:  Cynthia A Kelm-Nelson; Michael A Trevino; Michelle R Ciucci
Journal:  Neuroscience       Date:  2018-02-27       Impact factor: 3.590

3.  Purinergic Antagonism Prevents Mitochondrial Dysfunction and Behavioral Deficits Associated with Dopaminergic Toxicity Induced by 6-OHDA in Rats.

Authors:  Saket Kumar; Akanksha Mishra; Sairam Krishnamurthy
Journal:  Neurochem Res       Date:  2017-08-24       Impact factor: 3.996

4.  Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism.

Authors:  Guy Horev; Jacob Ellegood; Jason P Lerch; Young-Eun E Son; Lakshmi Muthuswamy; Hannes Vogel; Abba M Krieger; Andreas Buja; R Mark Henkelman; Michael Wigler; Alea A Mills
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

5.  Frequency-Specific Optogenetic Deep Brain Stimulation of Subthalamic Nucleus Improves Parkinsonian Motor Behaviors.

Authors:  Chunxiu Yu; Isaac R Cassar; Jaydeep Sambangi; Warren M Grill
Journal:  J Neurosci       Date:  2020-04-20       Impact factor: 6.167

6.  Modeling operant behavior in the Parkinsonian rat.

Authors:  Irene Avila; Mark P Reilly; Federico Sanabria; Diana Posadas-Sánchez; Claudia L Chavez; Nikhil Banerjee; Peter Killeen; Eddie Castañeda
Journal:  Behav Brain Res       Date:  2008-11-27       Impact factor: 3.332

7.  Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity.

Authors:  M G Ondrusek; C D Kilts; G D Frye; R B Mailman; R A Mueller; G R Breese
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis.

Authors:  Thomas S Guillot; Seneshaw A Asress; Jason R Richardson; Jonathan D Glass; Gary W Miller
Journal:  J Mot Behav       Date:  2008-11       Impact factor: 1.328

9.  A highly reproducible rotenone model of Parkinson's disease.

Authors:  Jason R Cannon; Victor Tapias; Hye Mee Na; Anthony S Honick; Robert E Drolet; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2009-05       Impact factor: 5.996

10.  Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits.

Authors:  Patrick J Schultheis; Sheila M Fleming; Amy K Clippinger; Jada Lewis; Taiji Tsunemi; Benoit Giasson; Dennis W Dickson; Joseph R Mazzulli; Mark E Bardgett; Kristi L Haik; Osunde Ekhator; Anil Kumar Chava; John Howard; Matt Gannon; Elizabeth Hoffman; Yinhuai Chen; Vikram Prasad; Stephen C Linn; Rafael J Tamargo; Wendy Westbroek; Ellen Sidransky; Dimitri Krainc; Gary E Shull
Journal:  Hum Mol Genet       Date:  2013-02-07       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.